Home Compliance Alere to Pay $38.75 Million to Settle Allegations Over Fatally Defective Blood... ComplianceNews Alere to Pay $38.75 Million to Settle Allegations Over Fatally Defective Blood Monitoring Devices July 15, 2021 12 Share FacebookLinkedinTwitter angellodeco | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Whistleblower Network News: DOJ Must Listen to the Whistleblower Community in Developing Whistleblower Program Compliance Staffing Company Settles Cybersecurity FCA Violation Case for $2.7M Compliance DOJ’s First Intervention in Cybersecurity FCA Qui Tam Case Signals Continued Cyber Enforcement